Vistagen develops nasal spray medicine candidates for conditions such as social anxiety disorder and depression. It last closed at $0.19 on Nov 17, up 2.01% on the day. VTGN reports earnings on Thu, Feb 11, 2027.
VTGN · as of the Nov 17 close · updated after every close
Downtrend
The stock sits between its 20 and 50 day averages. It is 123% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 48). The nearest support is the 20 day average at $0.18, and the nearest resistance the swing high (Nov 4) at $0.19.
Short trendBearish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 8.6%/day
Key levels
$5.1452 week high+2605.3%
$0.42200 day average+121.1%
$0.24100 day average+26.3%
$0.2250 day average+15.8%
$0.19Pivot R1+0.0%
$0.19Pivot+0.0%
$0.19Swing high (Nov 4)+0.0%
$0.19Last close
$0.1820 day average−5.3%
$0.18Pivot S1−5.3%
$0.17Swing low (Oct 30)−10.5%
$0.1652 week low−15.8%
Indicators
RSI (14)
47.73
Middle of its range
Neutral
MACD
-0.01
Below its signal line
Bearish
Stochastic
75.9
Middle of its range
Neutral
ADX (14)
10.1
No clear trend
Williams %R
-13.9
Oversold below −80, overbought above −20
Overbought
CCI (20)
84.1
Oversold below −100, overbought above 100
Neutral
Rate of change
+11.9%
Change over 10 sessions
Bullish
ATR (14)
$0.02
Typical daily range, 8.6% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 47.9%/day
Key levels
$5.1452 week high+2605.3%
$0.42200 day average+121.1%
$0.24100 day average+26.3%
$0.2250 day average+15.8%
$0.19Pivot R1+0.0%
$0.19Pivot+0.0%
$0.19Swing high (Nov 4)+0.0%
$0.19Last close
$0.1820 day average−5.3%
$0.18Pivot S1−5.3%
$0.17Swing low (Oct 30)−10.5%
$0.1652 week low−15.8%
Indicators
RSI (14)
31.76
Weak, oversold below 30
Neutral
MACD
-0.15
Above its signal line
Bullish
Stochastic
3.5
Near the bottom of its range
Oversold
ADX (14)
19.7
No clear trend
Williams %R
-93.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-111.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−20.7%
Change over 10 sessions
Bearish
ATR (14)
$0.09
Typical daily range, 47.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VTGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VTGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow VTGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How VTGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2011.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VTGN is in one of them and how their past VTGN trades turned out.
Vistagen is a pharmaceutical company based in South San Francisco, California, that is developing medicines for conditions including social anxiety disorder, depression, menopausal hot flashes, and cancer cachexia. Its candidates are nasal sprays designed to act on nerve receptors in the nose, with the aim of working without being absorbed into the bloodstream. The company has no approved products yet, and its candidates are being tested in clinical trials with patients.